Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohort

Arthritis Care and Research

Volumn 64, Issue 1, 2012, Pages 132-137

  Urowitz, M B ^a   Gladman, D D ^a   Ibanez D ^a   Fortin, P R ^a   Bae, S C ^b   Gordon, C ^c   Clarke, A ^d   Bernatsky, S ^d   Hanly, J G ^e   Isenberg, D ^f   Rahman, A ^g   Sanchez Guerrero, J ^g   Wallace, D J ^h   Ginzler, E ⁱ   Alarcon G S ^j   Merrill, J T ^k   Bruce, I N ^l   Sturfelt, G ^m   Nived, O ^m   Steinsson, K ⁿ   Khamashta, M ^o   Petri, M ^p   Manzi, S ^q   Ramsey Goldman, R ^r   Dooley, M A ^s   Van Vollenhoven, R F ^t   Ramos, M ^u   Stoll, T ^v   Zoma, A ^w   Kalunian, K ^x   Aranow, C ^y   more..

^a TORONTO WESTERN HOSPITAL   (Canada)

^b Hanyang University Medical Center   (South Korea)

^c UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^d MONTREAL GENERAL HOSPITAL   (Canada)

^e DALHOUSIE UNIVERSITY   (Canada)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

^g INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ SUNY DOWNSTATE MEDICAL CENTER   (United States)

^j UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^k OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^l UNIVERSITY OF MANCHESTER   (United Kingdom)

^m LUND UNIVERSITY HOSPITAL   (Sweden)

ⁿ LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^o ST THOMAS HOSPITAL   (United Kingdom)

^p JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^q ALLEGHENY GENERAL HOSPITAL   (United States)

^r NORTHWESTERN UNIVERSITY   (United States)

^s UNIVERSITY OF NORTH CAROLINA   (United States)

^t KAROLINSKA INSTITUTE   (Sweden)

^u Unidad de Enfermedades   (Spain)

^v KANTONSSPITAL   (Switzerland)

^w HAIRMYRES HOSPITAL   (United Kingdom)

^x UNIVERSITY OF CALIFORNIA   (United States)

^y NewYork Presbyterian Hospital   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CARDIOLIPIN ANTIBODY; CORTICOSTEROID; LUPUS ANTICOAGULANT;

ADULT; AFRICAN AMERICAN; ARTICLE; ASIAN; CLINICAL ASSESSMENT; CLINICAL CLASSIFICATION; CLINICAL PROTOCOL; COHORT ANALYSIS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE ACTIVITY; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HISPANIC; HUMAN; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; SCORING SYSTEM; STANDARDIZATION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADRENAL CORTEX HORMONES; ADULT; AFRICAN AMERICANS; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTINUCLEAR; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; COHORT STUDIES; COST OF ILLNESS; DISEASE PROGRESSION; DNA; EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; LINEAR MODELS; LUPUS COAGULATION INHIBITOR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; NORTH AMERICA; REGISTRIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; YOUNG ADULT;

EID: 84856866632     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/acr.20648     Document Type: Article

References (16)

1. Abu-Shakra M, Urowitz MB, Gladman DD, Gough J. Mortality studies in systemic lupus erythematosus: results from a single centre. II. Predictor variables for mortality. J Rheumatol 1995; 22:1265-70.
2. Cook RJ, Gladman DD, Pericak D, Urowitz MB. Prediction of short-term mortality in systemic lupus erythematosus with time-dependent measures of disease activity. J Rheumatol 2000;27:1892-5. (Pubitemid 30670482)
3. Ibanez D, Urowitz MB, Gladman DD. Disease activity over time (adjusted mean SLEDAI) predicts mortality and damage in SLE. J Rheumatol 2005;32:824-7. (Pubitemid 40676490)
4. Rahman P, Gladman DD, Urowitz MB, Hallett D, Tam LS. Early damage as measured by the SLICC/ACR Damage Index is a predictor of mortality in systemic lupus erythematosus. Lupus 2001;10:93-6. (Pubitemid 32410092)
5. Chambers SA, Allen E, Rahman A, Isenberg D. Damage and mortality in a group of British patients with systemic lupus erythematosus followed up for over 10 years. Rheumatology (Oxford) 2009;48:673-5.
6. Cardoso CR, Signorelli FV, Papi JA, Salles GF. Initial and accrued damage as predictors of mortality in Brazilian patients with systemic lupus erythematosus: a cohort study. Lupus 2008;17:1042-8.
7. Urowitz MB, Gladman DD, Tom BD, Ibanez D, Farewell VT. Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus. J Rheumatol 2008; 35:2152-8.
8. Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003;349:1526-33. (Pubitemid 37255038)
9. Hochberg MC, for the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus letter. Arthritis Rheum 1997;40:1725.
10. Gladman DD, Ibanez D, Urowitz MB. Systemic lupus ery-thematosus disease activity index 2000. J Rheumatol 2002;29: 288-91. (Pubitemid 34118775)
11. Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urow-itz M, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996;39:363-9. (Pubitemid 26085211)
12. Gladman D, Urowitz MB, Goldsmith CH, Fortin P, Ginzler E, Gordon C, et al. The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1997;40:809-13. (Pubitemid 27199995)
13. Erkan D, Zhang HW, Shriky RC, Merrill JT. Dual antibody reactivity to/32-glycoprotein I and protein S: increased association with thrombotic events in the antiphospholipid syndrome. Lupus 2002;11:215-20. (Pubitemid 34506725)
14. Nossent J, Kiss E, Rozman B, Pokorny G, Vlachoyiannopoulos P, Olesinska M, et al. Disease activity and damage accrual during the early disease course in a multinational inception cohort of patients with systemic lupus erythematosus. Lupus 2010;19:949-56.
15. Zhang J, Gonzalez LA, Roseman JM, Vila LM, Reveille JD, Alarcon GS. Predictors of the rate of change in disease activity over time in LUMINA, a multiethnic US cohort of patients with systemic lupus erythematosus: LUMINA LXX. Lupus 2010;19:727-33.
16. Gladman DD, Urowitz MB, Ibanez D, Rahman P, Tam LS. Accrual of organ damage in patients with systemic lupus erythematosus over time. J Rheumatol 2003;30:1955-9. (Pubitemid 37075543)